1. Lawton JS, Tamis-Holland JE, Bangalore S, et al. 2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation 2022; 145: e4-e17.
2.
Maron DJ, Hochman JS, Reynolds HR, et al.; ISCHEMIA Research Group. Initial invasive or conservative strategy for stable coronary disease. N Engl J Med 2020; 382: 1395-407.
3.
Doenst T, Schneider U, Can T, et al. Cardiac surgery 2021 reviewed. Thorac Cardiovasc Surg 2022; 70: 278-88.
4.
Schmidt AF, Haitjema S, Sartipy U, et al. Unravelling the difference between men and women in post-CABG survival. Front Cardiovasc Med 2022; 9: 768972.
5.
Urbanowicz T, Michalak M, Olasińska-Wiśniewska A, et al. Gender differences in coronary artery diameters and survival results after off-pump coronary artery bypass (OPCAB) procedures. J Thorac Dis 2021; 13: 2867-73.
6.
Duggan JP, Peters AS, Trachiotis GD, Antevil JL. Epidemiology of coronary artery disease. Surg Clin North Am 2022; 102: 499-516.
7.
Medina-Leyte DJ, Zepeda-García O, Domínguez-Pérez M, et al. Endothelial dysfunction, inflammation and coronary artery disease: potential biomarkers and promising therapeutical approaches. Int J Mol Sci 2021; 22: 3850.
8.
Grajek S, Michalak M, Urbanowicz T, Olasińska-Wiśniewska A. A meta-analysis evaluating the colchicine therapy in patients with coronary artery disease. Front Cardiovasc Med 2021; 8: 740896.
9.
Błażejowska E, Urbanowicz T, Gąsecka A, et al. Diagnostic and prognostic value of miRNAs after coronary artery bypass grafting: a review. Biology (Basel) 2021; 10: 1350.
10.
Amabile N, Rautou PE, Tedgui A, Boulanger CM. Microparticles: key protagonists in cardiovascular disorders. Semin Thromb Hemost 2010; 36: 907-16.
11.
Pirro M, Schillaci G, Paltriccia R, et al. Increased ratio of CD31+/CD42- microparticles to endothelial progenitors as a novel marker of atherosclerosis in hypercholesterolemia. Arterioscler Thromb Vasc Biol 2006; 26: 2530-5.
12.
Reddel CJ, Pennings GJ, Lau JK, et al. Circulating platelet-derived extracellular vesicles are decreased after remote ischemic preconditioning in patients with coronary disease: a randomized controlled trial. J Thromb Haemost. 2021; 19: 2605-11.
13.
Harky A, Sankaranarayanan V, Kong QG. Internal mammary artery: the primary conduit for surgical revascularization. Coron Artery Dis 2021; 32: 64-72.
14.
Tadokoro N, Fukushima S, Minami K, et al. 15-year outcomes of the JOCRI study (JOCRIED study): a randomised comparison of off-pump and on-pump multiple arterial coronary revascularisation. Gen Thorac Cardiovasc Surg 2023; 71: 151-7.
15.
Jegaden OJL, Farhat F, Jegaden MPO, et al. How decisive is the number of distal arterial anastomoses in coronary bypass surgery? J Cardiothorac Surg 2021; 16: 6-17.
16.
Farouk A, Hamed RA, Elsawy S, et al. Measuring the systemic inflammatory response to on- and off-pump coronary artery bypass graft (CABG) surgeries using the tryptophan/kynurenine pathway. J Invest Surg 2022; 35: 1621-5.
17.
Ladak SS, McQueen LW, Layton GR, et al. The role of endothelial cells in the onset, development and modulation of vein graft disease. Cells 2022; 11: 3066.
18.
Urbanowicz T, Olasińska-Wiśniewska A, Michalak M, et al. Pre-operative systemic inflammatory response index influences long-term survival rate in off-pump surgical revascularization. PLoS One 2022; 17: e0276138.
19.
Durk-Kozica M, Wróbel Am Platt M, Stepień E. Comparison of qNANO results from the isolation of extracellular microvesicles with the theoretical model. Bio-Algorithms and Med-Systems 2022; 18: 171-9.
20.
Welsh JA, Goberdhan DCI, O’Driscoll L, et al.; MISEV Consortium. Minimal information for studies of extracellular vesicles (MISEV2023): from basic to advanced approaches. J Extracell Vesicles 2024; 13: e12404.
21.
Stępień EŁ, Durak-Kozica M, Moskal P. Extracellular vesicles in vascular pathophysiology: beyond their molecular content. Pol Arch Intern Med 2023; 133: 16483-90.
22.
Magouliotis DE, Fergadi MP, Zotos PA, et al. Differences in long-term survival outcomes after coronary artery bypass grafting using single vs multiple arterial grafts: a meta-analysis with reconstructed time-to-event data and subgroup analyses. Gen Thorac Cardiovasc Surg 2023; 71: 77-89.
23.
Aboul-Hassan SS, Stankowski T, Perek B, et al. Coronary artery bypass surgery: comparing the long-term impact of total arterial grafting with multiarterial plus saphenous vein grafting. J Surg Res 2023; 290: 276-84.
24.
Xenogiannis I, Zenati M, Bhatt DL, et al. Saphenous vein graft failure: from pathophysiology to prevention and treatment strategies. Circulation 2021; 144: 728-45.
25.
Caliskan E, de Souza DR, Böning A, et al. Saphenous vein grafts in contemporary coronary artery bypass graft surgery. Nat Rev Cardiol 2020; 17: 155-69.
26.
Brown PA, Brown PD. Extracellular vesicles and atherosclerotic peripheral arterial disease. Cardiovasc Pathol 2023; 63: 107510.
27.
D’Ascenzo F, Femminò S, Ravera F, et al. Extracellular vesicles from patients with acute coronary syndrome impact on ischemia-reperfusion injury. Pharmacol Res 2021; 170: 105715.
28.
Abel F, Giebel B, Frey UH. Agony of choice: how anesthetics affect the composition and function of extracellular vesicles. Adv Drug Deliv Rev 2021; 175: 113813.
29.
McVey MJ, Kuebler WM. Extracellular vesicles: biomarkers and regulators of vascular function during extracorporeal circulation. Oncotarget 2018; 9: 37229-51.
30.
Meyer AD, Gelfond JA, Wiles AA, et al. Platelet-derived microparticles generated by neonatal extracorporeal membrane oxygenation systems. ASAIO J 2015; 61: 37-42.
31.
Hermiston ML, Xu Z, Weiss A. CD45: a critical regulator of signaling thresholds in immune cells. Annu Rev Immunol 2003; 21: 107-37.
32.
Zhuang L, Wang Y, Chen Z, et al. Global characteristics and dynamics of single immune cells after myocardial infarction. J Am Heart Assoc 2022; 11: e027228.
33.
Wang SM, Liu GQ, Xian HB, et al. LncRNA NEAT1 alleviates sepsis-induced myocardial injury by regulating the TLR2/NF-B signaling pathway. Eur Rev Med Pharmacol Sci 2019; 23: 4898-907.
34.
Martini E, Kunderfranco P, Peano C, et al. Single-cell sequencing of mouse heart immune infiltrate in pressure overload-driven heart failure reveals extent of immune activation. Circulation 2019; 140: 2089-107.
35.
Eyileten C, Jakubik D, Shahzadi A, et al. Diagnostic performance of circulating miRNAs and extracellular vesicles in acute ischemic stroke. Int J Mol Sci 2022; 23: 4530.
36.
Serrano CV Jr, Souza JA, Lopes NH, et al. Reduced expression of systemic proinflammatory and myocardial biomarkers after off-pump versus on-pump coronary artery bypass surgery: a prospective randomized study. J Crit Care 2010; 25: 305-12.
37.
Laurikka A, Vuolteenaho K, Toikkanen V, et al. Inflammatory glycoprotein YKL-40 is elevated after coronary artery bypass surgery and correlates with leukocyte chemotaxis and myocardial injury, a pilot study. Cells 2022; 11: 3378.
38.
Malik V, Kale SC, Chowdhury UK, et al. Myocardial injury in coronary artery bypass grafting: on-pump versus off-pump comparison by measuring heart-type fatty-acid-binding protein release. Tex Heart Inst J 2006; 33: 321-7.
39.
Angelillo-Scherrer A. Leukocyte-derived microparticles in vascular homeostasis. Circ Res 2012; 110: 356-69.
40.
Núñez J, Sanchis J, Bodí V, et al. Therapeutic implications of low lymphocyte count in non-ST segment elevation acute coronary syndromes. Eur J Intern Med 2009; 20: 768-74.
41.
Aung HH, Tung JP, Dean MM, et al. Procoagulant role of microparticles in routine storage of packed red blood cells: potential risk for prothrombotic post-transfusion complications. Pathology 2017; 49: 62-9.
42.
Papp J, Toth A, Sandor B, et al. The influence of on-pump and off-pump coronary artery bypass grafting on hemorheological parameters. Clin Hemorheol Microcirc 2011; 49: 331-46.